Eligibility for the Pfizer vaccine

The Australian Technical Advisory Group on Immunisation (ATAGI) recommends that access to the Pfizer vaccine is prioritised for those whom the Pfizer vaccine is the only COVID-19 vaccine currently recommended.

Who is eligible to receive a Pfizer Vaccination?  Vaccination providers can administer Pfizer to:

• all residential aged care workers aged 16 years or older;

the following people aged 16 to 39 years:

o quarantine and border workers and their household contacts,

o aged and disability care workers and disability care residents,

o healthcare workers,  critical and high risk workers,

o travellers with a travel exemption, o Aboriginal and Torres Strait Islander people,

o people with an underlying condition, and o pregnant women;

anyone aged between 40 and 59; and

• from 9 August 2021, the following groups aged 12 to 15: o children aged 12-15 with a specified medical condition that increase their risk of severe COVID-19 (including severe asthma, diabetes, obesity, cardiac and circulatory congenital anomalies, neuro developmental disorders, epilepsy, immune-compromised and trisomy 21),

Vaccination providers can also administer Pfizer to people aged 60 and over with:

• past history of cerebral venous sinus thrombosis (CVST)

• past history of Heparin-induced thrombocytopenia (HIT)

• past history of idiopathic splanchnic (mesenteric, portal, splenic) vein thrombosis ( not DVT or PE )

• antiphospholipid syndrome with thrombosis, and

• contraindications to COVID-19 Vaccine AstraZeneca. That means: o anaphylaxis to a previous dose or to an ingredient of the vaccine, o thrombosis with thrombocytopenia occurring after the first dose of AstraZeneca, or o other serious adverse event attributed to the first dose of AstraZeneca.

People aged 60 and over who do not have one of the conditions listed above are eligible to receive the AstraZeneca vaccine.